Latin America Hyaluronic Acid Dermal Filler Market Expansion to be Persistent During 2030

 Latin America Hyaluronic Acid Dermal Filler Market: Introduction

In terms of volume, the hyaluronic acid dermal filler market in Latin America is anticipated to expand at a CAGR of ~5% from 2020 to 2030. Strong growth of the hyaluronic acid dermal filler market in Latin America can be ascribed to the rise in medical tourism in the region. The cost of dermal filler procedure is lower in Latin America than that in other regions. Therefore, the demand for dermal filler procedures has been rising in Latin America. Countries such as Brazil, Mexico, and Argentina report significant number of patients for dermal filler procedures from the U.S. and countries in Europe. The increase in penetration of the Internet in developed and developing countries provides consumers an opportunity to research on various dermal filler procedures available for the treatment of skin and facial ailments. This boosts online sales. Additionally, advantage of product comparison, rise in desire to maintain youthful features, and increase in fad of using anti-aging products, owing to the growth in social media awareness are contributing to growth of the hyaluronic acid dermal filler market in Latin America. The rise in demand for non-surgical cosmetic products such as cosmetic injectable in Brazil and Mexico drives the hyaluronic acid dermal filler market in Latin America. The growth in medical tourism in Brazil and Mexico is also boosting the demand for hyaluronic acid dermal filler in the region.

Get Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79720

Clinical Risks and Complications Associated With Hyaluronic Acid Dermal Filler to Hamper Market

The hyaluronic acid dermal filler market in Latin America is anticipated to be hampered by high cost of products and availability of cost-effective substitute products. Clinical risks and complications associated with hyaluronic acid dermal fillers are also expected to hamper the market in the region in the near future. The lack of regulations governing the usage of dermal fillers leads to exploitation by untrained workers in salons and beauty parlors. The current legislation in place does not classify dermal filler as prescription medicine, leading to administration of these to patients at discounted price by non-clinicians. Thus, lack of regulations governing clinics and practitioners is likely to hamper the hyaluronic acid dermal filler market in Latin America in during the forecast period.

Enquiry Before Buying:https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79720

Monophasic Type Dominated Latin America Hyaluronic Acid Dermal Filler Market in 2019

Based on type, the hyaluronic acid dermal filler market in Latin America has been bifurcated into biphasic and monophasic. In terms of value, the monophasic segment dominated the hyaluronic acid dermal filler market in Latin America in 2019. The segment is anticipated to expand at a CAGR of more than 5.5% during the forecast period.

Use of Hyaluronic Acid Dermal Fillers to Treat Wrinkles

Based on application, the hyaluronic acid dermal filler market in Latin America has been segregated into wrinkles, lips, cheek augmentation, hands, and others. In terms of value, the wrinkles segment led the hyaluronic acid dermal filler market in Latin America in 2019. The segment is anticipated to expand at a CAGR of more than 5% during the forecast period.

Purchase A Report-https://www.globenewswire.com/news-release/2022/05/05/2436840/0/en/Polyaspartic-Coatings-Market-to-Reach-Valuation-of-US-931-Mn-by-2027-TMR-Study.html

Brazil to be Lucrative Country of Latin America Hyaluronic Acid Dermal Filler Market

Based on country & sub-region, the hyaluronic acid dermal filler market in Latin America has been classified into Brazil, Mexico, Argentina, Colombia, Chile, Peru, Ecuador, and Rest of Latin America. In terms of volume, Brazil accounted for significant share of the hyaluronic acid dermal filler in Latin America in 2019. Quick recovery time, less trauma, painless treatment, and lower cost as compared to surgical procedures are driving the demand for hyaluronic acid dermal filler market in the country. The demand for lip enhancement has been increasing rapidly in Argentina, owing to the growing fad of the selfie culture. The market for lip enhancement has been expanding significantly, owing to rise in young population preferring to modify their lips for a plump and voluminous appearance. This offers lucrative opportunities to the hyaluronic acid dermal filler market in Argentina.

Competition Landscape of Latin America Hyaluronic Acid Dermal Filler Market

On May 8, 2020, AbbVie completed the acquisition of Allergen Plc under the Chapter 1 of Part 9 of the Irish Companies Act 2014. On March 26, 2019, Allergen acquired Envy Medical, Inc. for US$ 81.4 Mn. Envy Medical, Inc. is a privately held medical esthetics company engaged in non-surgical and non-invasive skin resurfacing systems. The acquisition combines Envy’s skin care product portfolio with the company’s leading medical esthetics business.

On April 5, 2019, Merz launched the new hyaluronic acid (HA) dermal filler ‘Belotero Revive.’ Belotero Revive is applied through an injection as a beauty booster and for youthful radiance.  The product contains a unique combination of hyaluronic acid (HA) and glycerol. It is intended to improve elasticity, hydration, and firmness of the skin and minimize early signs of aging. In April 2018, LG Chem launched a premium hyaluronic acid filler Yvoire Y-Solution. The product line includes three products: Y-Solution 360 for fine wrinkles; Y-Solution 540 for forehead and zygoma; and Y-Solution 720 for nasolabial folds and wrinkles around the cheek and jaw.

Leading players have taken initiatives to increase their presence in Latin America through expansion of supply & distribution network as well as strategic partnerships. Key manufacturers operating in the hyaluronic acid dermal filler market in Latin America are Allergen, LG Chem, Ltd., Galderma, Teoxane, BioPlus Co., Ltd., Merz Pharma, Medytox, Adoderm GmbH, Sinclair Pharma, Bloomage Biotechnology Corp. Ltd., Bohus BioTech AB, and HUGEL, Inc.

Comments

Popular posts from this blog

Compresed Fiberboard Market Size, Analytical Overview, Growth Factors, Demand, Trends And Forecast To 2027

Maqui Berries Market Positive Outlook for Industry Opportunities & Trends for Expansion during 2018-2028

Polyurethane Screen Panels Market is Projected to Garner Significant Revenues by 2030